Eclipse Prism Medical Devices Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 15-11-2024
- Paid Up Capital ₹ 0.30 M
as on 15-11-2024
- Company Age 41 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.18 Cr
as on 15-11-2024
- Revenue 9.96%
(FY 2023)
- Profit 29.21%
(FY 2023)
- Ebitda 28.00%
(FY 2023)
- Net Worth 18.64%
(FY 2023)
- Total Assets 46.03%
(FY 2023)
About Eclipse Prism Medical Devices
The Corporate was formerly known as Shree Gandha Chemicals Pvt Ltd. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹6.18 Cr.
Milind Nagare and Priyal Nagare serve as directors at the Company.
- CIN/LLPIN
U24110MH1983PTC029923
- Company No.
029923
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 May 1983
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Eclipse Prism Medical Devices Private Limited offer?
Eclipse Prism Medical Devices Private Limited offers a wide range of products and services, including Forceps & Graspers, Surgical Equipments, Endoscopy & Laparoscopy instruments, Endoscopic Accessories, Surgical Pendant, Surgical Light, Operation Theatre Lights, Patient Monitoring System, Surgical Monitor.
Who are the key members and board of directors at Eclipse Prism Medical Devices?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Priyal Nagare  | Director | 28-Sep-2014 | Current |
| Milind Nagare | Director | 16-Apr-2010 | Current |
Financial Performance of Eclipse Prism Medical Devices.
Eclipse Prism Medical Devices Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.96% increase. The company also saw a substantial improvement in profitability, with a 29.21% increase in profit. The company's net worth Soared by an impressive increase of 18.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eclipse Prism Medical Devices?
In 2023, Eclipse Prism Medical Devices had a promoter holding of 99.00% and a public holding of 1.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 05 Nov 2024 | ₹4.51 M | Open |
Others Creation Date: 05 Nov 2024 | ₹0.61 M | Open |
Others Creation Date: 05 Nov 2024 | ₹2.50 Cr | Open |
How Many Employees Work at Eclipse Prism Medical Devices?
Eclipse Prism Medical Devices has a workforce of 48 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eclipse Prism Medical Devices, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eclipse Prism Medical Devices's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
